Your browser doesn't support javascript.
loading
Adjuvant intravesical treatment for nonmuscle invasive bladder cancer: The importance of the strain and maintenance. / Tratamiento adyuvante intravesical en cáncer de vejiga no músculo invasivo: importancia de la cepa y el mantenimiento.
Guerrero-Ramos, F; Lara-Isla, A; Justo-Quintas, J; Duarte-Ojeda, J M; de la Rosa-Kehrmann, F; Villacampa-Aubá, F.
Afiliación
  • Guerrero-Ramos F; Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, España. Electronic address: felixguerrero@gmail.com.
  • Lara-Isla A; Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, España.
  • Justo-Quintas J; Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, España.
  • Duarte-Ojeda JM; Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, España.
  • de la Rosa-Kehrmann F; Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, España.
  • Villacampa-Aubá F; Servicio de Urología, Hospital Universitario 12 de Octubre, Madrid, España.
Actas Urol Esp ; 41(9): 590-595, 2017 Nov.
Article en En, Es | MEDLINE | ID: mdl-28457495
ABSTRACT
BACKGROUND AND

OBJECTIVE:

Intravesical Bacille Calmette-Guérin (BCG) is essential for preventing the recurrence and progression of superficial bladder tumours. The aim of our study was to compare the efficacy and toxicity of the Connaught and Tice strains, as well as the importance of the maintenance regimen. MATERIAL AND

METHODS:

We retrospectively reviewed 110 patients with superficial bladder tumours who underwent adjuvant endovesical treatment. The patients were distributed into 3 groups, based on whether the treatment was with the Connaught strain, the Tice strain or both sequentially. We calculated the relapse-free survival rate in each group and compared the patients who completed the maintenance treatments against those who did not. To identify the predictors of relapse, we performed a multivariate analysis. We also assessed the toxicity by analysing the onset of BCGitis, urinary urgency, fever, urinary tract infection and treatment withdrawing due to adverse effects.

RESULTS:

We found no differences in the efficacy parameters. The patients in the Connaught group completed the maintenance to a lesser extent (38.4 vs. 72% for the Tice group and 76.3% for both groups; P=.010). The patients who completed the maintenance had better relapse-free survival at 60 months (88.5 vs. 74.2%; P=.036), regardless of the strain employed. The multivariate analysis identified a size larger than 3cm, more than 3 implants and not completing the maintenance as risk factors of relapse. The patients with the Connaught strain had higher rates of BCGitis, with no differences in the other events studied.

CONCLUSION:

Completing the maintenance phase is essential, regardless of the strain employed. The Connaught strain has a greater risk of BCGitis, and a sequential regimen could be useful in certain scenarios.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Vacuna BCG / Adyuvantes Inmunológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Actas Urol Esp Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Vacuna BCG / Adyuvantes Inmunológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En / Es Revista: Actas Urol Esp Año: 2017 Tipo del documento: Article